{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:12:56Z","timestamp":1767651176301},"reference-count":36,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1429,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1365-2036.2011.04855.x","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T03:19:33Z","timestamp":1317698373000},"page":"1235-1244","source":"Crossref","is-referenced-by-count":23,"title":["The use of nonsteroidal anti-inflammatory drugs and the risk of Barrett\u2019s oesophagus"],"prefix":"10.1111","volume":"34","author":[{"given":"A. P.","family":"Thrift","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Pandeya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. M.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. C.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,3]]},"reference":[{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1053\/gast.2002.33427","article-title":"Barrett\u2019s esophagus","volume":"122","author":"Falk","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1158\/1055-9965.EPI-10-0012","article-title":"Esophageal adenocarcinoma incidence: are we reaching the peak?","volume":"19","author":"Pohl","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.5694\/j.1326-5377.2009.tb02813.x","article-title":"Adenocarcinoma of the oesophagus: incidence and survival rates in New South Wales, 1972-2005","volume":"191","author":"Stavrou","year":"2009","journal-title":"Med J Aust"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/gast.2000.9302","article-title":"Is there publication bias in the reporting of cancer risk in Barrett\u2019s esophagus?","volume":"119","author":"Shaheen","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cgh.2009.10.010","article-title":"Risk of esophageal adenocarcinoma and mortality in patients with Barrett\u2019s esophagus: a systematic review and meta-analysis","volume":"8","author":"Sikkema","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/canjclin.56.2.69","article-title":"Chronic inflammation: a common and important factor in the pathogenesis of neoplasia","volume":"56","author":"Schottenfeld","year":"2006","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"7908","DOI":"10.1038\/sj.onc.1203286","article-title":"The role of cyclooxygenases in inflammation, cancer, and development","volume":"18","author":"Williams","year":"1999","journal-title":"Oncogene"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues","volume":"94","author":"Thun","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nat New Biol"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0049-3848(03)00379-7","article-title":"The mechanism of action of aspirin","volume":"110","author":"Vane","year":"2003","journal-title":"Thromb Res"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1572-0241.2002.05528.x","article-title":"NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action","volume":"97","author":"Husain","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2407-3-28","article-title":"Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis","volume":"3","author":"Gonzalez-Perez","year":"2003","journal-title":"BMC Cancer"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB15|cit15","first-page":"559","article-title":"Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)","volume":"13","author":"Harris","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1158\/0008-5472.CAN-05-4253","article-title":"Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence","volume":"66","author":"Anderson","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1158\/1055-9965.EPI-07-0664","article-title":"Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County","volume":"17","author":"Duan","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1158\/1055-9965.EPI-07-2852","article-title":"Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus","volume":"17","author":"Sadeghi","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","article-title":"Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis","volume":"124","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB21|cit21","first-page":"198","article-title":"Cyclooxygenase-2 expression in human esophageal carcinoma","volume":"59","author":"Zimmermann","year":"1999","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2559.2003.01627.x","article-title":"Cyclooxygenase-2 is expressed frequently and early in Barrett\u2019s oesophagus and associated adenocarcinoma","volume":"42","author":"Lagorce","year":"2003","journal-title":"Histopathology"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0016-5085(00)70254-X","article-title":"Cyclooxygenase 2 expression in Barrett\u2019s esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure","volume":"118","author":"Shirvani","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB24|cit24","first-page":"990","article-title":"Cyclooxygenase-2 expression in the Barrett\u2019s metaplasia-dysplasia-adenocarcinoma sequence","volume":"96","author":"Morris","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1158\/1055-9965.EPI-05-0370","article-title":"Interactions among smoking, obesity, and symptoms of acid reflux in Barrett\u2019s esophagus","volume":"14","author":"Smith","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.cgh.2009.04.018","article-title":"Current and past smoking significantly increase risk for Barrett\u2019s esophagus","volume":"7","author":"Smith","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S1470-2045(05)70431-9","article-title":"Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett\u2019s oesophagus: a prospective study","volume":"6","author":"Vaughan","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1053\/j.gastro.2010.02.045","article-title":"Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett\u2019s esophagus","volume":"138","author":"Nguyen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1371\/journal.pmed.0040067","article-title":"NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma","volume":"4","author":"Galipeau","year":"2007","journal-title":"PLoS Med"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/CEJ.0b013e32832e0955","article-title":"Aspirin is not chemoprotective for Barrett\u2019s adenocarcinoma of the oesophagus in multicentre cohort","volume":"18","author":"Gatenby","year":"2009","journal-title":"Eur J Cancer Prev"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.jaad.2005.05.049","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin","volume":"53","author":"Butler","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1076\/opep.10.1.37.13776","article-title":"Systemic use of anti-inflammatory medications and age-related maculopathy: the Blue Mountains Eye Study","volume":"10","author":"Wang","year":"2003","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB33|cit33","volume-title":"National Health Survey: Summary of Results 2007-08","author":"Australian Bureau of Statistics","year":"2009"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00268-008-9780-9","article-title":"Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community","volume":"33","author":"Watson","year":"2009","journal-title":"World J Surg"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.gastro.2007.05.026","article-title":"Central adiposity and risk of Barrett\u2019s esophagus","volume":"133","author":"Edelstein","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1365-2036.2011.04855.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1111\/j.1572-0241.2002.05910.x","article-title":"Updated guidelines for the diagnosis, surveillance, and therapy of Barrett\u2019s esophagus","volume":"97","author":"Sampliner","year":"2002","journal-title":"Am J Gastroenterol"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2011.04855.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2036.2011.04855.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T21:28:36Z","timestamp":1625434116000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2011.04855.x"}},"subtitle":["NSAID use and the risk of Barrett\u2019s oesophagus"],"short-title":[],"issued":{"date-parts":[[2011,10,3]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04855.x","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10,3]]}}}